Menlo Ventures Announces Cohort Backed by the $100M Anthology Fund Launched in Partnership with Anthropic
18 déc. 2024 11h00 HE
|
Menlo Ventures
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Menlo Ventures, a leading venture capital firm investing at the forefront of AI, announced its first cohort of 18 companies backed by the $100...
FE International Expands Fundraising Services with Funden Partnership
17 déc. 2024 09h00 HE
|
FE International
FE International partners with Funden to connect early-stage founders to 1,100+ VCs, offering M&A expertise and fundraising support to drive growth.
YL Ventures Identifies key Cybersecurity Sectors set to Dominate in 2025
10 déc. 2024 13h10 HE
|
YL Ventures
SAN FRANCISCO and TEL AVIV, Israel, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Global cybersecurity venture capital firm, YL Ventures, today released its predictions for the most promising cybersecurity...
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21 nov. 2024 09h00 HE
|
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
Menlo Ventures’ 2024 State of Generative AI Report Reveals 6x Spike in Enterprise Spending as Market Leaders Shift
20 nov. 2024 14h30 HE
|
Menlo Ventures
MENLO PARK, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Menlo Ventures, a leading venture capital firm investing at the forefront of AI, released its second annual State of Generative AI in the...
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
18 nov. 2024 08h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
18 nov. 2024 02h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
14 nov. 2024 08h00 HE
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
14 nov. 2024 03h00 HE
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
11x Raises a $50 Million Series B Led by Andreessen Horowitz to Accelerate the Era of Digital Workers
11 nov. 2024 12h00 HE
|
11X AI INC.
SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by...